CRIS
CURIS INC
NASDAQ · Healthcare · Biotechnology · US
$1.02
−6.42%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$2.29
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$4.02
- EPS estimate
- -$5.70
- Revenue actual
- —
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -73.8%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$5.70 | -$4.02 | Beat 29.47% | — |
| May 12, 2026 | -$0.29 | -$1.25 | Miss -331.03% | — |
| Mar 19, 2026 | -$0.44 | -$0.50 | Miss -14.68% | $1.1M |
| Nov 6, 2025 | -$0.62 | -$0.49 | Beat 20.97% | $3.2M |
| Mar 31, 2025 | -$1.36 | -$1.25 | Beat 8.09% | $3.3M |
| Nov 14, 2024 | -$1.88 | -$1.70 | Beat 9.57% | $2.9M |
| Aug 1, 2024 | -$1.70 | -$2.03 | Miss -19.41% | $2.5M |
| Feb 8, 2024 | -$1.91 | -$2.03 | Miss -6.28% | $2.7M |
| Dec 21, 2023 | — | -$2.58 | — | $2.9M |
| Aug 3, 2023 | -$2.40 | -$2.40 | In line | $2.2M |
| May 4, 2023 | -$2.20 | -$2.40 | Miss -9.09% | $2.3M |
| Nov 9, 2022 | -$3.40 | -$2.80 | Beat 17.65% | $2.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026